Plenary Lectures
SHIRANEE SRISKANDAN
'Streptococcal Lymphatic Metastasis: Bacterial Close Encounters of the Fourth Kind'
Shiranee Sriskandan is Professor of Infectious Diseases at Imperial College London and an Infectious Diseases clinical consultant.  She leads the Gram Positive Pathogenesis research group, in addition to the molecular bacteriology work of the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, in partnership with Public Health England, and Imperial's Biomedical Research Centre. Her research group addresses the mechanisms by which Streptococcus pyogenes causes extreme clinical phenotypes in individuals and populations, examining the interface between pathogen molecular microbiology and host immune response.

Having trained in medicine at Cambridge University, she obtained her PhD in London, then held MRC and GSK postdoctoral research fellowships. She has held expert advisory roles in relation to maternal sepsis, use of intravenous immunoglobulin, streptococcal vaccines, and streptococcal prevention in healthcare and household settings.


SALLY C. DAVIES
'Antimicrobial Resistance: From Problem to Policy to Action'
Professor Dame Sally Davies is England’s Chief Medical Officer (CMO), and the Chief Scientific Adviser for the Department of Health. As CMO she is the independent advisor to the Government on all medical matters, particularly Public Health. The CMO also advises the Health Secretary on medical matters and promoting the health and well being of the people of England. She carries the rank of Permanent Secretary and is the professional head of the Department’s medical staff and head of the Medical Civil Service. Prof. Davies has been actively involved in NHS R&D from its establishment. As Director-General she established the National Institute for Health Research (NIHR) with a budget of £1 billion. Her own research interests focused on Sickle Cell disease.

Long an active participant in WHO, Prof. Davies led the UK delegation to the Ministerial Summit in November 2004 and the Forum on Health Research in November 2008. She spoke on R&D at the World Health Assembly in May 2005 and serves the WHO Global Advisory Committee on Health Research. She also chaired the Expert Advisory Committee for the development of the WHO research strategy. She is a member of the International Advisory Committee for A*STAR, Singapore and has advised many other organizations on research strategy and evaluation.
Prof. Davies was awarded a DBE (Dame Commander of the British Empire) in the New Year Honours 2009 for services to medicine. In September 2011 she was conferred as Emeritus Professor at Imperial College London.

CHING-LUNG LAI

'Challenges and Opportunities in the Management of Chronic Hepatitis B Infection'

Ching-Lung Lai is the Simon K Y Lee Professor in Gastroenterology and the Chair Professor of Medicine and Hepatology at the Department of Medicine, University of Hong Kong, where he has been working since his graduation.

 

For the last three decades he has been extensively involved in research into various aspects of HBV, including hepatocellular carcinoma. He is one of the lead investigators in the pivotal trials of various nucleos(t)ide analogues which have revolutionised the treatment of chronic hepatitis B. He and his colleagues have also been investigating the still emerging field of the natural history of chronic hepatitis B, with findings which have an important bearing on the treatment end-points for chronic hepatitis B.

 

Professor Lai has published over 450 peer-reviewed papers and reviews in international journals. His publications have been widely cited and he is one of top scientists in the field of chronic hepatitis B infection. He has also been awarded multiple awards by the University of Hong Kong for his outstanding teaching.

SOUMYA SWAMINATHAN
'Tuberculosis: Challenges and Solutions in the 21st Century'
Dr. Swaminathan is a pediatrician by training, having completed her medical education at the Armed Forces Medical College and the All India Institute of Medical Sciences followed by a fellowship in pediatric pulmonology at the Children’s Hospital of Los Angeles. She has spent over 24 years at the Tuberculosis Research Centre in Chennai, (now renamed the National Institute for Research in Tuberculosis), where she is currently the Director.
She has over 200 peer-reviewed publications and serves on many national and international committees. Her major research interests are in pediatric and adult TB, their interaction with HIV and nutrition and the management of co-infections as well as pharmacokinetics and pharmacogenetics.

She is an elected Fellow of three of India’s Science Academies and chaired the HIV section of the International Union against TB and Lung Diseases 2011–2013. She also served as Coordinator for Neglected Priorities Research at WHO/TDR, Geneva 2009–2011. She is the recipient of several awards for excellence in biomedical sciences.

Dr. Swaminathan was appointed as Director General of the Indian Council of Medical Research (ICMR) and Secretary, Department of Health Research (Ministry of Health & Family Welfare) in August 2015. She will head a network of 32 research centres under ICMR, the apex body for coordination and promotion of biomedical research in India
PAUL ANANTHARAJAH TAMBYAH
'Zika, MERS, Ebola, SARS and H1N1: Local and Global Responses to Viral Threats'

Paul Anantharajah Tambyah is currently Professor of Medicine at the National University of Singapore and Senior Consultant Infectious Diseases Physician at the National University Hospital. He is also Research Director in the Division of Infectious Diseases of the National University Health System. After graduating from the National University of Singapore, he did his postgraduate training at the University of Wisconsin under Dr Dennis Maki and since returning to Singapore in 1999 he has held a number of academic, professional and advisory appointments including Assistant Dean of the Yong Loo Lin School of Medicine. He is immediate past President of the Society of Infectious Diseases (Singapore) and Secretary-General of the Asia Pacific Society of Clinical Microbiology and Infection.


NICHOLAS JOHN WHITE

Ronald Ross Memorial Plenary Lecture
'Malaria: Past, Present and Future'

Nick White, Professor of Tropical Medicine at the Faculty of Tropical Medicine, Mahidol University, Thailand and at Oxford University, UK, and Consultant Physician at the John Radcliffe Hospital, Oxford, is a Wellcome Trust Principal Research Fellow who chairs the Wellcome Trust Tropical Medicine Research Programmes in South
East Asia. He trained in medicine in London at Guy’s Hospital and he has lived and worked in Thailand since 1980. His research focus is the pathophysiology and treatment of malaria. He has concentrated on characterising antimalarial pharmacokinetic-pharmacodynamic relationships to improve the treatment of malaria and to reduce the emergence of resistance. This led to artemisinin based combination treatment for falciparum malaria, and the change to artesunate for the treatment of severe malaria.

 

He has authored over 900 scientific publications and 40 book chapters. He currently chairs the WorldWide Antimalarial Resistance Network and he co-chairs the WHO Global Malaria Programme technical expert group on the prevention and treatment of malaria, and the WHO antimalarial treatment guidelines committee.

 

[The Ronald Ross Memorial Lecture recognizes the contributions of Dr. Ronald Ross in discovering the mosquito transmission of malaria. Ross was awarded the Nobel Prize in Medicine in 1902 for his work on malaria and he has laid the foundation for successful research on this disease and methods of combating it. His groundbreaking research was conducted in Hyderabad in what is today called the Sir Ronald Ross Institute of Parasitology].